World Wires · story 20872 · unverified · 1 source(s)

Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform

A new patent application covers Polyrizon’s proprietary mucoadhesive platform and its potential applications in nasal drug delivery.

Open in the desk

Coverage

• Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform GlobeNewswire: public companies · tier D · clear net · 2026-10-05 11:32 UTC

What this site indexes